Neogenomics (NEO) Depreciation & Amortization (CF) (2010 - 2026)

Neogenomics (NEO) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $8.6 million in Q2 2026.

• Quarterly Depreciation & Amortization (CF) fell 6.17% year-over-year to $8.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $34.9 million (down 8.0% YoY) and the FY2025 annual result came in at $36.1 million, down 7.75% from the prior year.
• Depreciation & Amortization (CF) eased to $8.6 million in Q2 2026, from $8.8 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $9.9 million in Q1 2024 to a low of $8.4 million in Q1 2022.
• A 5-year average of $9.2 million and a median of $9.2 million in 2023 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) advanced 25.67% — and 2025, when it retreated 10.83%.
• Tracing NEO's Depreciation & Amortization (CF) over 5 years: stood at $9.5 million in 2022, then grew by 1.06% to $9.6 million in 2023, then advanced by 2.6% to $9.8 million in 2024, then dropped by 10.83% to $8.8 million in 2025, then slipped by 2.12% to $8.6 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $8.6 million (Q2 2026), $8.8 million (Q1 2026), and $8.8 million (Q4 2025), per Business Quant data.